- Home
- WTFCM vs MIST Comparison
WTFCM vs MIST Comparison
Compare WTFCM & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTFCM
- MIST
- Stock Information
- Founded
- WTFCM N/A
- MIST 2003
- Country
- WTFCM United States
- MIST Canada
- Employees
- WTFCM 5903
- MIST N/A
- Industry
- WTFCM Major Banks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- WTFCM Finance
- MIST Health Care
- Exchange
- WTFCM Nasdaq
- MIST Nasdaq
- Market Cap
- WTFCM N/A
- MIST 89.8M
- IPO Year
- WTFCM N/A
- MIST N/A
- Fundamental
- Price
- WTFCM $24.96
- MIST $1.94
- Analyst Decision
- WTFCM
- MIST Strong Buy
- Analyst Count
- WTFCM 0
- MIST 2
- Target Price
- WTFCM N/A
- MIST $7.50
- AVG Volume (30 Days)
- WTFCM N/A
- MIST 566.3K
- Earning Date
- WTFCM N/A
- MIST 08-07-2025
- Dividend Yield
- WTFCM N/A
- MIST N/A
- EPS Growth
- WTFCM N/A
- MIST N/A
- EPS
- WTFCM N/A
- MIST N/A
- Revenue
- WTFCM N/A
- MIST N/A
- Revenue This Year
- WTFCM N/A
- MIST N/A
- Revenue Next Year
- WTFCM N/A
- MIST N/A
- P/E Ratio
- WTFCM N/A
- MIST N/A
- Revenue Growth
- WTFCM N/A
- MIST N/A
- 52 Week Low
- WTFCM N/A
- MIST $0.63
- 52 Week High
- WTFCM N/A
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- WTFCM 28.03
- MIST 65.73
- Support Level
- WTFCM $24.94
- MIST $1.86
- Resistance Level
- WTFCM $25.36
- MIST $1.97
- Average True Range (ATR)
- WTFCM 0.02
- MIST 0.10
- MACD
- WTFCM -0.05
- MIST 0.00
- Stochastic Oscillator
- WTFCM 5.90
- MIST 80.00
About WTFCM Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series D
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).